A Statistical Understanding of Polyclonality in Monoclonal Antibody Production
Therapies based on monoclonal antibodies (mAbs) are among the most powerful medical technologies to have been developed in recent years. From treatments designed to attack cancer cells and prevent rejection following organ transplants to methods for treating infectious diseases such as anthrax and COVID-19, the applications for mAbs continue to grow. And that’s before uses…